RNA Next-Generation Sequencing Market 2021: Global Status & Forecast by Geography, Type & Application (2017-2027)

Summary

The Global RNA Next-Generation Sequencing Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global RNA Next-Generation Sequencing market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific
North America
Europe
South America
Middle East & Africa

Key Companies

Roche
Illumina
Thermo Fisher Scientific
Beckman Coulter
Abbott Molecular
Pacific Biosciences
Oxford Nanopore Technologies
Eurofins Scientific
Macrogen
GENEWIZ
BGI
Berry Genomics
QIAGEN

Key Product Type

Enrichment Approaches
Amplicon-Based Approaches

Market by Application

Research Institutes
Hospitals and Clinics
Biotechnology Company
Diagnostic Lab

Main Aspects covered in the Report

Overview of the RNA Next-Generation Sequencing market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development

If you have any special requirements, please let us know and we will offer you the report as you want.

1 Industrial Chain Overview

1.1 RNA-based Biopharmaceuticals Industry

1.1.1 Overview

Figure RNA-based Biopharmaceuticals Picture List

1.1.2 Characteristics of RNA-based Biopharmaceuticals

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Therapeutics

1.3.2 Vaccines

1.4 End-Use List

1.4.1 Demand in Cancer

1.4.2 Demand in Diabetes

1.4.3 Demand in Tuberculosis

1.4.4 Demand in Cardiovascular Diseases

1.4.5 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2017-2027

Figure Global Market Size and Forecast with Growth Rate, 2017-2027

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027

Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027

Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027

Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2017-2021, in Volume

Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2017-2021, in Volume

Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD

Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2017-2021, in Volume

Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD

Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume

Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2021

3.2 Manufacturers List

3.2.1 Pfizer Overview

Table Pfizer Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Roche Overview

Table Roche Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Roche (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Sanofi-Aventis Overview

Table Sanofi-Aventis Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Sanofi-Aventis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Abbott Laboratories Overview

Table Abbott Laboratories Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Abbott Laboratories (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Arrowhead Pharmaceuticals Overview

Table Arrowhead Pharmaceuticals Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Arrowhead Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Benitec Biopharma Overview

Table Benitec Biopharma Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Benitec Biopharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Calimmune Inc Overview

Table Calimmune Inc Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Calimmune Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Dicerna Overview

Table Dicerna Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Dicerna (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Gradalis Overview

Table Gradalis Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Gradalis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Quark Overview

Table Quark Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Quark (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 RXi Overview

Table RXi Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of RXi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Senesco Overview

Table Senesco Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Senesco (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Silence Therapeutics Overview

Table Silence Therapeutics Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Silence Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Silenseed Overview

Table Silenseed Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Silenseed (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Tekmira Overview

Table Tekmira Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Tekmira (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Alnylam Pharmaceuticals Overview

Table Alnylam Pharmaceuticals Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table RNA-based Biopharmaceuticals Business Operation of Alnylam Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2017-2021, in Volume

Figure Global Market Size and Growth Rate, 2017-2021, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2017-2021, in Volume

Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume

Figure Global Production Volume Share by Manufacturers in 2021, in Volume

Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD

Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD

Figure Global Production Amount Share by Manufacturers in 2021, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Therapeutics

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Therapeutics, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Therapeutics, 2017-2021, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Vaccines

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Vaccines, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Vaccines, 2017-2021, in Volume

5.2.2.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume

6.2 Segment Subdivision

6.2.1 Market in Cancer

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Cancer, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Cancer, 2017-2021, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Diabetes

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Diabetes, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Diabetes, 2017-2021, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Tuberculosis

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Tuberculosis, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Tuberculosis, 2017-2021, in Volume

6.2.3.2 Situation & Development

6.2.4 Market in Cardiovascular Diseases

6.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Cardiovascular Diseases, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Cardiovascular Diseases, 2017-2021, in Volume

6.2.4.2 Situation & Development

6.2.5 Market in Others

6.2.5.1 Market Size

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume

6.2.5.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2022-2027, in Million USD

Table Global Market Forecast by Region Segment 2022-2027, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2022-2027, in Million USD

Table Global Market Volume by Product Type Segment 2022-2027, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2022-2027, in Million USD

Table Global Market Volume by End-Use Segment 2022-2027, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the RNA-based Biopharmaceuticals Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures